<DOC>
	<DOCNO>NCT00776919</DOCNO>
	<brief_summary>This Randomized , Double-Blind , Controlled Study evaluate Safety Efficacy clindamycin / benzoyl peroxide gel Subjects Acne Vulgaris</brief_summary>
	<brief_title>Trial Clindamycin / Benzoyl Peroxide Gel Subjects With Acne</brief_title>
	<detailed_description>A multicenter , randomize , double-blind , comparator vehicle-controlled study subject acne vulgaris . Approximately 1320 subject enrol . Subjects randomize 1 4 parallel study group 1:1:1:1 ratio ( clindamycin / benzoyl peroxide gel : clindamycin gel : BPO gel : vehicle gel ) .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>Be 12 45 year age , inclusive , good general health . Clinical diagnosis acne vulgaris Females childbearing potential participating study must agree use medically acceptable method contraception receive protocolassigned product . Have ability willingness follow study procedure , attend schedule visit , successfully complete study . Have ability understand sign write informed consent form , must complete prior study specific task perform . Subjects legal age consent state/province/country study conduct must provide assent write informed consent parent guardian . Are pregnant breastfeeding . Have history presence condition may increase risk subject participate study and/or affect evaluate outcomes . Used topical antibiotic face use systemic antibiotic within past 2 week . Used topical corticosteroid face systemic corticosteroid within past 4 week . Use inhale , intraarticular , intralesional steroid facial acne acceptable . Used systemic retinoids within past 6 month topical retinoids within past 6 week . Received treatment estrogen ( include oral , implanted , injected topical contraceptive ) , androgens , antiandrogenic agent 12 week less immediately prior start study product . Subjects treat estrogen , describe , androgen , antiandrogenic agent 12 consecutive week prior start study product allow enroll long expect change dose , drug , discontinue use study . Used topical antiacne medication ( eg , BPO , azelaic acid , resorcinol , salicylate , etc . ) within past 2 week . Used abradents facial procedure , within past 2 week . Use medication may exacerbate acne . Have know hypersensitivity previous allergic reaction active component , lincomycin , excipients study product . Used investigational therapy within past 4 week , currently participate another clinical study .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Acne Vulgaris</keyword>
	<keyword>Acne</keyword>
</DOC>